Pentothal and hyperkalaemia Patient Reports February 13, 2012

Pentothal Side Effects Report #4665033-9
Pentothal side effect was reported by a Physician from on May 09, 2005. Female patient, 35 years of age, was diagnosed with sedation and was treated with Pentothal. After drug was administered, patient experienced the following side effects: cardiac arrest , fluid retention, haemodialysis, haemodynamic instability, hyperkalaemia, hypokalaemia, post procedural complication, tachycardia, uterine enlargement. Pentothal dosage: 2-3MG.KG-1, INTRAVENOUS. During the same period patient was treated with MIDAZOLAM, SUFENTANIL CITRATE, NIMBEX. Patient died.

Pentothal Side Effects Report #5723581-4
Pentothal side effect was reported by a Consumer or non-health professional from CANADA on Apr 15, 2008. Male patient, 53 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal. After drug was administered, patient experienced the following side effects: cardiac arrest , hyperkalaemia, hypokalaemia, rebound effect. Pentothal dosage: 5 MG/KG, ONCE, INTRAVENOUS BOLUS; 3.75 MG/KG/HR, INFUSION. During the same period patient was treated with CHLORIDE, MANNITOL, PROPOFOL, PHENYTOIN, NOREPINEPHRINE BITARTRATE, ANTIBIOTIC, INSULIN, FENTANYL. Patient recovered.

Pentothal Side Effects Report #5723589-9
Pentothal side effect was reported by a Consumer or non-health professional from CANADA on Apr 15, 2008. Male patient, 32 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal. After drug was administered, patient experienced the following side effects: hyperkalaemia, hypokalaemia, rebound effect. Pentothal dosage: unknown. During the same period patient was treated with CHLORIDE, MANNITOL, PROPOFOL, PHENYTOIN, NOREPINEPHRINE BITARTRATE, VASOPRESSIN. Patient recovered.

Pentothal Side Effects Report #5723555-3
Pentothal side effect was reported by a Consumer or non-health professional from CANADA on Apr 15, 2008. Female patient, 24 years of age, was diagnosed with intracranial pressure increased and was treated with Pentothal. After drug was administered, patient experienced the following side effects: hyperkalaemia, hypokalaemia, ventricular tachycardia. Pentothal dosage: 3 MG/KG, ONCE, INTRAVENOUS BOLUS; 5 MG/KG/HR, CONTINUOUS INFUSION; 3 MG/KG/HR, CONTINUOUS INFUSION. During the same period patient was treated with CHLORIDE, MANNITOL, PROPOFOL, PHENYTOIN, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, ANTIBIOTIC, MORPHINE. Patient recovered.